Correction to "The New Frontier: Merging Molecular Glue Degrader and Antibody-Drug Conjugate Modalities To Overcome Strategic Challenges"

Yam B Poudel,Ruchita R Thakore,Eugene P Chekler

DOI: https://doi.org/10.1021/acs.jmedchem.4c02447

IF: 8.039

2024-10-19

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Oct 18. doi: 10.1021/acs.jmedchem.4c02447. Online ahead of print. NO

chemistry, medicinal

What problem does this paper attempt to address?

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Cheng Wang,Xuerong Liu,Shaoqing Chen,Fuqiang Hu,Jihong Sun,Hong Yuan

DOI: https://doi.org/10.1039/c8cc07694d

IF: 4.9

2018-01-01

Chemical Communications

Abstract:Correction for 'Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration' by Cheng Wang et al., Chem. Commun., 2018, 54, 13080-13083, DOI: 10.1039/C8CC07694D.
Addition/Correction to "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy"

Andrew D. Huber,Young-Hwan Jung,Yongtao Li,Wenwei Lin,Jing Wu,Shyaron Poudel,Annalise G. Carrigan,Ashutosh Mishra,Anthony A. High,Taosheng Chen

DOI: https://doi.org/10.1021/acs.jmedchem.4c02834

IF: 8.039

2024-11-28

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Nov 27. doi: 10.1021/acs.jmedchem.4c02834. Online ahead of print. NO

chemistry, medicinal
Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells"

Patricia Grabher,Paul Kapitza,Nikolas Hörmann,Amelie Scherfler,Martin Hermann,Michael Zwerger,Hristo P. Varbanov,Brigitte Kircher,Daniel Baecker,Ronald Gust

DOI: https://doi.org/10.1021/acs.jmedchem.4c00799

IF: 8.039

2024-04-24

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Apr 23. doi: 10.1021/acs.jmedchem.4c00799. Online ahead of print. NO

chemistry, medicinal
Correction to “Rational Chemical Design of Molecular Glue Degraders”

Ethan S Toriki,James W Papatzimas,Kaila Nishikawa,Dustin Dovala,Andreas O Frank,Matthew J Hesse,Daniela Dankova,Jae-Geun Song,Megan Bruce-Smythe,Heidi Struble,Francisco J Garcia,Scott M Brittain,Andrew C Kile,Lynn M McGregor,Jeffrey M McKenna,John A Tallarico,Markus Schirle,Daniel K Nomura,Ethan S. Toriki,James W. Papatzimas,Andreas O. Frank,Matthew J. Hesse,Francisco J. Garcia,Scott M. Brittain,Andrew C. Kile,Lynn M. McGregor,Jeffrey M. McKenna,John A. Tallarico,Daniel K. Nomura

DOI: https://doi.org/10.1021/acscentsci.3c00844

IF: 18.2

2023-07-21

ACS Central Science

Abstract:[This corrects the article DOI: 10.1021/acscentsci.2c01317.].

chemistry, multidisciplinary
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Geetika Dhanda,Yash Acharya,Jayanta Haldar

DOI: https://doi.org/10.1021/acsomega.4c05153

IF: 4.1

2024-06-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00312.][This corrects the article DOI: 10.1021/acsomega.3c03063.].
Correction to "A Vancomycin-Templated DNA-Encoded Library for Combating Drug-Resistant Bacteria"

Dongliang Guan,Jiaxiang Liu,Feifei Chen,Jian Li,Xiaowen Wang,Weiwei Lu,Yanrui Suo,Feng Tang,Lefu Lan,Xiaojie Lu,Wei Huang

DOI: https://doi.org/10.1021/acs.jmedchem.4c00607

IF: 8.039

2024-04-04

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Apr 2. doi: 10.1021/acs.jmedchem.4c00607. Online ahead of print. NO

chemistry, medicinal
Correction to "Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements"

Zheng Chen,Maoyu Liu,Ningyu Wang,Wenjing Xiao,Jianyou Shi

DOI: https://doi.org/10.1021/acs.jmedchem.4c01106

IF: 8.039

2024-05-23

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 May 22. doi: 10.1021/acs.jmedchem.4c01106. Online ahead of print. NO

chemistry, medicinal
Correction: Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties

Adrian D. Hobson,Haizhong Zhu,Wei Qiu,Russell A. Judge,Kenton Longenecker

DOI: https://doi.org/10.1039/d4md90009j

2024-01-01

RSC Medicinal Chemistry

Abstract:Correction for ‘Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties’ by Adrian D. Hobson et al. , RSC Med. Chem. , 2024, https://doi.org/10.1039/d3md00540b.

biochemistry & molecular biology,chemistry, medicinal
The antibody–drug conjugate landscape

Patrick Flynn,Smruthi Suryaprakash,Dan Grossman,Val Panier,John Wu

DOI: https://doi.org/10.1038/d41573-024-00064-w

IF: 112.288

2024-04-17

Nature Reviews Drug Discovery

Abstract:Nature Reviews Drug Discovery, Published online: 16 April 2024; doi:10.1038/d41573-024-00064-w The antibody–drug conjugate landscape

pharmacology & pharmacy,biotechnology & applied microbiology
Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Qiang Cheng,Yuyan Li,Wei Huang,Ke Li,Minhuan Lan,Benhua Wang,Jianxiu Wang,Xiangzhi Song

DOI: https://doi.org/10.1039/d3cc90149a

IF: 4.9

2023-05-12

Chemical Communications

Abstract:Correction for 'Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy' by Qiang Cheng et al. , Chem. Commun. , 2023, https://doi.org/10.1039/d3cc01107k.

chemistry, multidisciplinary
Correction to "Conjugated Coordination Porphyrin-based Nanozymes for Photo-/Sono-Augmented Biocatalytic and Homologous Tumor Treatments"

Fangxue Du,Luchang Liu,Ling Li,Jianbo Huang,Liyun Wang,Yuanjiao Tang,Bowen Ke,Li Song,Chong Cheng,Lang Ma,Li Qiu

DOI: https://doi.org/10.1021/acsami.4c17682

IF: 9.5

2024-11-01

ACS Applied Materials & Interfaces

Abstract:ACS Appl Mater Interfaces . 2024 Oct 31. doi: 10.1021/acsami.4c17682. Online ahead of print. NO

materials science, multidisciplinary,nanoscience & nanotechnology
Correction to "The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology"

R. Justin Grams,Webster L. Santos,Ion Romulus Scorei,Antonio Abad-García,Carol Ann Rosenblum,Andrei Bita,Hugo Cerecetto,Clara Viñas,Marvin A. Soriano-Ursúa

DOI: https://doi.org/10.1021/acs.chemrev.4c00307

IF: 62.1

2024-05-29

Chemical Reviews

Abstract:Chem Rev. 2024 May 28. doi: 10.1021/acs.chemrev.4c00307. Online ahead of print. NO

chemistry, multidisciplinary
Correction to "Janus ACSP Nanoparticle for Synergistic Chemodynamic Therapy and Radiosensitization"

Mingzhen Xu,Yuyi Qian,Xinyi Li,Bingxin Gu,Simin He,Xin Lu,Shaoli Song

DOI: https://doi.org/10.1021/acsami.4c07552

IF: 9.5

2024-06-06

ACS Applied Materials & Interfaces

Abstract:ACS Appl Mater Interfaces . 2024 Jun 5. doi: 10.1021/acsami.4c07552. Online ahead of print. NO

materials science, multidisciplinary,nanoscience & nanotechnology
Correction: A zinc–porphyrin–peptide conjugate via "click-chemistry": synthesis and amyloid-β interaction

Rita Tosto,Stefania Zimbone,Giuseppe Di Natale,Maria Laura Giuffrida,Tiziana Campagna,Giuseppe Pappalardo,Giuseppina Sabatino

DOI: https://doi.org/10.1039/d4nj90117g

IF: 3.3

2024-09-02

New Journal of Chemistry

Abstract:Correction for 'A zinc–porphyrin–peptide conjugate via "click-chemistry": synthesis and amyloid-β interaction' by Rita Tosto et al. , New J. Chem. , 2024, 48 , 13010–13020, https://doi.org/10.1039/D4NJ02162B.

chemistry, multidisciplinary
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody–drug conjugates

Min Sun Kang,Theresa Wai See Kong,Joycelyn Yi Xin Khoo,Teck-Peng Loh

DOI: https://doi.org/10.1039/d1sc02973h

IF: 8.4

2021-01-01

Chemical Science

Abstract:The review shall introduce and analyse the current developments in the chemical modification of native amino acids on peptides or proteins and their applicability to ADC linkers.
Correction to "α 3 β 1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment"

Yan Zou,Yinping Sun,Beibei Guo,Yaohua Wei,Yifeng Xia,Zhenyuan Huangfu,Fenghua Meng,Jan C. M. van Hest,Jiandong Yuan,Zhiyuan Zhong

DOI: https://doi.org/10.1021/acsami.4c07760

IF: 9.5

2024-05-22

ACS Applied Materials & Interfaces

Abstract:ACS Appl Mater Interfaces . 2024 May 21. doi: 10.1021/acsami.4c07760. Online ahead of print. NO

materials science, multidisciplinary,nanoscience & nanotechnology
Antibody Conjugates-Recent Advances and Future Innovations

Donmienne Leung,Jacqueline M. Wurst,Tao Liu,Ruben M. Martinez,Amita Datta-Mannan,Yiqing Feng

DOI: https://doi.org/10.3390/antib9010002

2020-01-01

Antibodies

Abstract:Monoclonal antibodies have evolved from research tools to powerful therapeutics in the past 30 years. Clinical success rates of antibodies have exceeded expectations, resulting in heavy investment in biologics discovery and development in addition to traditional small molecules across the industry. However, protein therapeutics cannot drug targets intracellularly and are limited to soluble and cell-surface antigens. Tremendous strides have been made in antibody discovery, protein engineering, formulation, and delivery devices. These advances continue to push the boundaries of biologics to enable antibody conjugates to take advantage of the target specificity and long half-life from an antibody, while delivering highly potent small molecule drugs. While the "magic bullet" concept produced the first wave of antibody conjugates, these entities were met with limited clinical success. This review summarizes the advances and challenges in the field to date with emphasis on antibody conjugation, linker-payload chemistry, novel payload classes, absorption, distribution, metabolism, and excretion (ADME), and product developability. We discuss lessons learned in the development of oncology antibody conjugates and look towards future innovations enabling other therapeutic indications.
Correction to "Modular Click Assembly DNA-Encoded Glycoconjugate Libraries with on-DNA Functional Group Transformations"

Xing Ling,Sixiu Liu,Yixuan Yang,Qian Dong,Lisa A Marcaurelle,Wei Huang,Yun Ding,Xuan Wang,Xiaojie Lu,Lisa A. Marcaurelle

DOI: https://doi.org/10.1021/acs.bioconjchem.4c00085

IF: 4.7

2024-03-26

Bioconjugate Chemistry

Abstract:Bioconjug Chem . 2024 Mar 25. doi: 10.1021/acs.bioconjchem.4c00085. Online ahead of print. NO

chemistry, multidisciplinary,biochemistry & molecular biology, organic,biochemical research methods
Emerging formats for next-generation antibody drug conjugates

Mahendra P Deonarain,Gokhan Yahioglu,Ioanna Stamati,Jared Marklew

DOI: https://doi.org/10.1517/17460441.2015.1025049

Abstract:Introduction: Antibody drug conjugates now make up a significant fraction of biopharma's oncology pipeline due to great advances in the understanding of the three key components and how they should be optimised together. With this clinical success comes innovation to produce new enabling technologies that can deliver more effective antibody-drug conjugates (ADCs) with a larger therapeutic index. Areas covered: There are many reviews that discuss the various strategies for ADCs design but the last 5 years or so have witnessed the emergence of a number of different antibody formats compete with the standard whole immunoglobulin. Using published research, patent applications and conference disclosures, the authors review the many antibody and antibody-like formats, discussing innovations in protein engineering and how these new formats impact on the conjugation strategy and ultimately the performance. The alternative chemistries that are now available offer new linkages, stability profiles, drug:antibody ratio, pharmacokinetics and efficacy. The different sizes being considered promise to address issues, such as tumour penetration, circulatory half-life and side-effects. Expert opinion: ADCs are at the beginning of the next stage in their evolution and as these newer formats are developed and examined in the clinic, we will discover if the predicted features have a clinical benefit. From the commercial activity, it is envisaged that smaller or fragment-based ADCs will expand oncological applications.

Correction to "The New Frontier: Merging Molecular Glue Degrader and Antibody-Drug Conjugate Modalities To Overcome Strategic Challenges"

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Addition/Correction to "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy"

Correction to "Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor-Positive Tumor Cells"

Correction to “Rational Chemical Design of Molecular Glue Degraders”

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Correction to "A Vancomycin-Templated DNA-Encoded Library for Combating Drug-Resistant Bacteria"

Correction to "Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements"

Correction: Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties

The antibody–drug conjugate landscape

Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Correction to "Conjugated Coordination Porphyrin-based Nanozymes for Photo-/Sono-Augmented Biocatalytic and Homologous Tumor Treatments"

Correction to "The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology"

Correction to "Janus ACSP Nanoparticle for Synergistic Chemodynamic Therapy and Radiosensitization"

Correction: A zinc–porphyrin–peptide conjugate via "click-chemistry": synthesis and amyloid-β interaction

Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody–drug conjugates

Correction to "α 3 β 1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment"

Antibody Conjugates-Recent Advances and Future Innovations

Correction to "Modular Click Assembly DNA-Encoded Glycoconjugate Libraries with on-DNA Functional Group Transformations"

Emerging formats for next-generation antibody drug conjugates